PMID- 18470306 OWN - NLM STAT- MEDLINE DCOM- 20080925 LR - 20220223 IS - 0091-6765 (Print) IS - 1552-9924 (Electronic) IS - 0091-6765 (Linking) VI - 116 IP - 5 DP - 2008 May TI - Formyl-methionyl-leucyl-phenylalanine-induced dopaminergic neurotoxicity via microglial activation: a mediator between peripheral infection and neurodegeneration? PG - 593-8 LID - 10.1289/ehp.11031 [doi] AB - BACKGROUND: Parkinson disease (PD), a chronic neurodegenerative disease, has been proposed to be a multifactorial disorder resulting from a combination of environmental mechanisms (chemical, infectious, and traumatic), aging, and genetic deficits. Microglial activation is important in the pathogenesis of PD. OBJECTIVES: We investigated dopaminergic (DA) neurotoxicity and the underlying mechanisms of formyl-methionyl-leucyl-phenylalanine (fMLP), a bacteria-derived peptide, in relation to PD. METHODS: We measured DA neurotoxicity using a DA uptake assay and immunocytochemical staining (ICC) in primary mesencephalic cultures from rodents. Microglial activation was observed via ICC, flow cytometry, and superoxide measurement. RESULTS: fMLP can cause selective DA neuronal loss at concentrations as low as 10(-13) M. Further, fMLP (10(-13) M) led to a significant reduction in DA uptake capacity in neuron/glia (N/G) cultures, but not in microglia-depleted cultures, indicating an indispensable role of microglia in fMLP-induced neurotoxicity. Using ICC of a specific microglial marker, OX42, we observed morphologic changes in activated microglia after fMLP treatment. Microglial activation after fMLP treatment was confirmed by flow cytometry analysis of major histocompatibility antigen class II expression on a microglia HAPI cell line. Mechanistic studies revealed that fMLP (10(-13) M)-induced increase in the production of extracellular superoxide from microglia is critical in mediating fMLP-elicited neurotoxicity. Pharmacologic inhibition of NADPH oxidase (PHOX) with diphenylene-iodonium or apocynin abolished the DA neurotoxicity of fMLP. N/G cultures from PHOX-deficient (gp91PHOX-/ -) mice were also insensitive to fMLP-induced DA neurotoxicity. CONCLUSION: fMLP (10(-13) M) induces DA neurotoxicity through activation of microglial PHOX and subsequent production of superoxide, suggesting a role of fMLP in the central nervous system inflammatory process. FAU - Gao, Xi AU - Gao X AD - Neuropharmacology Section, Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC 27709, USA. FAU - Hu, Xiaoming AU - Hu X FAU - Qian, Li AU - Qian L FAU - Yang, Sufen AU - Yang S FAU - Zhang, Wei AU - Zhang W FAU - Zhang, Dan AU - Zhang D FAU - Wu, Xuefei AU - Wu X FAU - Fraser, Alison AU - Fraser A FAU - Wilson, Belinda AU - Wilson B FAU - Flood, Patrick M AU - Flood PM FAU - Block, Michelle AU - Block M FAU - Hong, Jau-Shyong AU - Hong JS LA - eng GR - Intramural NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Intramural PL - United States TA - Environ Health Perspect JT - Environmental health perspectives JID - 0330411 RN - 59880-97-6 (N-Formylmethionine Leucyl-Phenylalanine) RN - EC 1.6.3.- (NADPH Oxidases) RN - VTD58H1Z2X (Dopamine) SB - IM MH - Animals MH - Cells, Cultured MH - Central Nervous System Infections/*etiology/metabolism/pathology MH - Dopamine/*metabolism MH - Enzyme Activation MH - Female MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Microglia/*drug effects/enzymology/metabolism MH - N-Formylmethionine Leucyl-Phenylalanine/*toxicity MH - NADPH Oxidases/metabolism MH - Neurodegenerative Diseases/*chemically induced/metabolism/pathology MH - Neurons/drug effects/metabolism MH - Oxidative Stress MH - Parkinson Disease/*etiology MH - Pregnancy MH - Rats MH - Rats, Inbred F344 PMC - PMC2367670 OTO - NOTNLM OT - NADPH oxidase OT - fMLP OT - inflammation OT - microglia OT - neurotoxicity EDAT- 2008/05/13 09:00 MHDA- 2008/09/26 09:00 PMCR- 2008/05/01 CRDT- 2008/05/13 09:00 PHST- 2007/10/30 00:00 [received] PHST- 2008/01/28 00:00 [accepted] PHST- 2008/05/13 09:00 [pubmed] PHST- 2008/09/26 09:00 [medline] PHST- 2008/05/13 09:00 [entrez] PHST- 2008/05/01 00:00 [pmc-release] AID - ehp0116-000593 [pii] AID - 10.1289/ehp.11031 [doi] PST - ppublish SO - Environ Health Perspect. 2008 May;116(5):593-8. doi: 10.1289/ehp.11031.